With the rising number of coronavirus-infected patients and the simplicity with which lockdown may be implemented over the world, demand for COVID-19 diagnostic tools is expected to soar even higher. According to World metre, the total number of cases increased from 33,556,252 positive patients on September 28, 2020 to 55,961,380 positive patients on November 17, 2020. Despite the predicted progressive drop in the number of positive patients in 2021, the market for COVID-19 diagnostics is expected to rise due to the incorporation of COVID-19 tests into standard diagnostic protocols.
Furthermore, these testing programmes are expected to help the travel sector ramp up, producing a favourable climate for companies selling Covid-19 diagnostics. The tourism and travel industries have been the worst hit by the pandemic, prompting an increase in COVID-19 Rapid Diagnostic Test Market testing programmes beyond August 2020, especially in tourist-dependent nations and areas. This is also projected to boost the market penetration of proof-of-concept testing, as these tests are able to overcome the limits of traditional testing.
